{"id":364,"date":"2026-01-16T13:08:30","date_gmt":"2026-01-16T12:08:30","guid":{"rendered":"https:\/\/menopause.projecttac.com\/?page_id=364"},"modified":"2026-01-31T23:01:09","modified_gmt":"2026-01-31T22:01:09","slug":"leitlinien-und-empfehlungen","status":"publish","type":"page","link":"https:\/\/menopause.projecttac.com\/fr\/leitlinien-und-empfehlungen\/","title":{"rendered":"Lignes directrices et recommandations"},"content":{"rendered":"\n<div style=\"height:28px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-group has-global-padding is-layout-constrained wp-block-group-is-layout-constrained\">\n<div class=\"wp-block-group has-global-padding is-content-justification-left is-layout-constrained wp-container-core-group-is-layout-12dd3699 wp-block-group-is-layout-constrained\">\n<p><strong>Traiter les patientes<\/strong><\/p>\n\n\n\n<p>Dans cette rubrique, la SSEGM met \u00e0 disposition des lignes directrices fond\u00e9es sur des preuves, des prises de position et des recommandations sp\u00e9cialis\u00e9es sur des th\u00e8mes centraux de l&rsquo;endocrinologie gyn\u00e9cologique, de la contraception et de la m\u00e9decine de la m\u00e9nopause.<\/p>\n\n\n\n<p>Ces contenus s&rsquo;adressent aux m\u00e9decins et visent \u00e0 favoriser des soins de haute qualit\u00e9 centr\u00e9s sur la patiente.<\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-group alignfull has-global-padding is-layout-constrained wp-block-group-is-layout-constrained has-background\" style=\"border-style:none;border-width:0px;border-top-left-radius:0px;border-top-right-radius:0px;border-bottom-left-radius:0px;border-bottom-right-radius:0px;min-height:1000px;background-image:url(&apos;https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/Buecherstapel-hoch3.png&apos;);background-position:87% 0%;background-size:cover;background-attachment:scroll;\">\n<div class=\"wp-block-group alignfull has-background has-global-padding is-layout-constrained wp-block-group-is-layout-constrained\" style=\"border-top-left-radius:0px;border-top-right-radius:0px;border-bottom-left-radius:0px;border-bottom-right-radius:0px;background:linear-gradient(90deg,rgb(255,255,255) 2%,rgba(255,255,255,0.4) 100%)\">\n<div class=\"wp-block-group has-global-padding is-content-justification-left is-layout-constrained wp-container-core-group-is-layout-87300e40 wp-block-group-is-layout-constrained\" style=\"border-top-left-radius:0px;border-top-right-radius:0px;border-bottom-left-radius:0px;border-bottom-right-radius:0px;padding-right:var(--wp--preset--spacing--80);padding-left:0\">\n<div style=\"height:28px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-accent-3-color has-text-color has-link-color wp-elements-2d1e70a3dc0e4e1626e1607652c1f00c\"><strong><strong>Endocrinologie gyn\u00e9cologique<\/strong><\/strong><\/p>\n\n\n\n<div class=\"wp-block-group has-global-padding is-layout-constrained wp-container-core-group-is-layout-e0082cf6 wp-block-group-is-layout-constrained\">\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Ob\u00e9sit\u00e9<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2024-AWMF-050-001l-S3-Praevention-und-Therapie-der-Adipositas.pdf\">2024 &#8211; AWMF 050-001l S3 &#8211; Therapie und Pr\u00e4vention der Adipositas<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2024-AWMF-050-002l-S3-Therapie-und-Praevention-der-Adipositas-im-Kindes-und-Jugendalter.pdf\" data-type=\"link\" data-id=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2024-AWMF-050-002l-S3-Therapie-und-Praevention-der-Adipositas-im-Kindes-und-Jugendalter.pdf\">2024 &#8211; AWMF 050-002l S3 &#8211; Therapie und Pr\u00e4vention der Adipositas im Kindes- und Jugendalter<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Saignements ut\u00e9rins anormaux<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2018-Munro-The-two-FIGO-systems-for-normal-and-abnormal-uterine-bleeding-symptoms-in-the-reproductive-years.pdf\" data-type=\"link\" data-id=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2018-Munro-The-two-FIGO-systems-for-normal-and-abnormal-uterine-bleeding-symptoms-in-the-reproductive-years.pdf\">2018 &#8211; Munro &#8211; The two FIGO systems for normal and abnormal uterine bleeding symptoms in the reproductive years<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2018-Munro-Corrigendum-to-The-two-FIGO-systems-for-normal-and-abnormal-uterine-bleeding-in-the-reproductive-years-1.pdf\" data-type=\"link\" data-id=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2018-Munro-Corrigendum-to-The-two-FIGO-systems-for-normal-and-abnormal-uterine-bleeding-in-the-reproductive-years-1.pdf\">2018 &#8211; Munro &#8211; Corrigendum to The two FIGO systems for normal and abnormal uterine bleeding in the reproductive years<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Am\u00e9norrh\u00e9e et troubles du cycle menstruel<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2017-Endocrine-Clinical-Society-Guideline-Functional-Hypothalamic-Amenorrhea-1.pdf\">2017 &#8211; Endocrine Clinical Society Guideline &#8211; Functional Hypothalamic Amenorrhea<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2024-ASRM-committee-opinion-Current-evaluation-of-amenorrhea.pdf\">2024 &#8211; ASRM committee opinion &#8211; Current evaluation of amenorrhea<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Androg\u00e9nisation \/ hyperandrog\u00e9nie<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2018-Endocrine-Society-Clinical-Practice-Guideline-Congenital-Adrenal-Hyperplasia-Due-to-Steroid-21-Hydroxylase-Deficiency-1.pdf\">2018 &#8211; Endocrine Society Clinical Practice Guideline &#8211; Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2018-Endocrine-Society-Clinical-Prcatice-Guideline-Evaluation-and-Treatment-of-Hirsutism-in-Premenopausal-Women-1.pdf\">2018 &#8211; Endocrine Society Clinical Prcatice Guideline &#8211; Evaluation and Treatment of Hirsutism in Premenopausal Women<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Endom\u00e9triose<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2025-AWMF-015-045l-S2k-Diagnostik-und-Therapie-der-Endometriose.pdf\" data-type=\"link\" data-id=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2025-AWMF-015-045l-S2k-Diagnostik-und-Therapie-der-Endometriose.pdf\">2025 &#8211; AWMF 015-045l S2k &#8211; Diagnostik und Therapie der Endometriose<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Malformations g\u00e9nitales<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2020-AWMF-015-052l-S1-Weibliche-genitale-Fehlbildungen.pdf\" data-type=\"link\" data-id=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2020-AWMF-015-052l-S1-Weibliche-genitale-Fehlbildungen.pdf\">2020 &#8211; AWMF 015-052l S1 &#8211; Weibliche genitale Fehlbildungen<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Hyperprolactin\u00e9mie<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2023-Endocrine-Society-clinical-practice-guideline-Diagnosis-and-treatment-of-hyperprolactinemia.pdf\" data-type=\"link\" data-id=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2023-Endocrine-Society-clinical-practice-guideline-Diagnosis-and-treatment-of-hyperprolactinemia.pdf\">2023 &#8211; Endocrine Society clinical practice guideline &#8211; Diagnosis and treatment of hyperprolactinemia<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2023-Pituitary-Society-international-Consensus-Statement-Diagnosis-and-management-of-prolactin-secreting-pituitary-adenomas.pdf\" data-type=\"link\" data-id=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2023-Pituitary-Society-international-Consensus-Statement-Diagnosis-and-management-of-prolactin-secreting-pituitary-adenomas.pdf\">2023 &#8211; Pituitary Society international Consensus Statement &#8211; Diagnosis and management of prolactin-secreting pituitary adenomas<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Infertilit\u00e9 \/ st\u00e9rilit\u00e9<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2019-AWMF-015-085l-S2k-Diagnostik-und-Therapie-vor-ART.pdf\">2019 &#8211; AWMF 015-085l S2k &#8211; Diagnostik und Therapie vor ART<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2021-ASRM-committee-opinion-Fertility-evaluation-of-infertile-women.pdf\">2021 &#8211; ASRM committee opinion &#8211; Fertility evaluation of infertile women<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Syndrome adr\u00e9nog\u00e9nital \u00e0 apparition tardive<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2018-Endocrine-Society-Clinical-Practice-Guideline-Congenital-Adrenal-Hyperplasia-Due-to-Steroid-21-Hydroxylase-Deficiency-1.pdf\">2018 &#8211; Endocrine Society Clinical Practice Guideline &#8211; Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Insuffisance lut\u00e9ale<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2021-ASRM-a-committee-opinion-Diagnosis-and-treatment-of-luteal-phase-deficiency.pdf\">2021 &#8211; ASRM a committee opinion &#8211; Diagnosis and treatment of luteal phase deficiency<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Ost\u00e9oporose<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2021-IMS-White-Paper-Update-on-bone-health.pdf\">2021 &#8211; IMS White Paper &#8211; Update on bone health<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2023-AWMF-183-001l-S3-Osteoporose-Prophylaxe-Diagnostik-und-Therapie.pdf\">2023 &#8211; AWMF 183-001l S3 &#8211; Osteoporose &#8211; Prophylaxe, Diagnostik und Therapie<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Syndrome des ovaires polykystiques<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2023-Recommendations-From-the-2023-International-Evidence-based-Guideline-for-the-Assessment-and-Management-of-PCOS.pdf\">2023 &#8211; Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of PCOS<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2025-AWMF-089-004l-S2k-Diagnostik-und-Therapie-des-PCOS.pdf\" data-type=\"link\" data-id=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2025-AWMF-089-004l-S2k-Diagnostik-und-Therapie-des-PCOS.pdf\">2025 &#8211; AWMF 089-004l S2k &#8211; Diagnostik und Therapie des PCOS<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Syndrome pr\u00e9menstruel<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2013-ISPMD-consensus-on-the-management-of-premenstrual-disorders-1.pdf\">2013 &#8211; ISPMD consensus on the management of premenstrual disorders<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2023-ACOG-Clinical-Practice-Guideline-Management-of-Premenstrual-Disorders.pdf\">2023 &#8211; ACOG Clinical Practice Guideline &#8211; Management of Premenstrual Disorders<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Troubles de la pubert\u00e9 (par ex. pubert\u00e9 pr\u00e9coce et tardive)<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2011-AWMF-027-025l-S1-Pubertas-tarda-und-Hypogonadismus-1.pdf\">2011 &#8211; AWMF 027-025l S1 &#8211; Pubertas tarda und Hypogonadismus<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2019-APED-Stoerungen-der-Pubertaetsentwicklung.pdf\">2019 &#8211; APED &#8211; St\u00f6rungen der Pubert\u00e4tsentwicklung<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2019-AWMF-174-015l-S1-Pubertas-praecox.pdf\">2019 &#8211; AWMF 174-015l S1 &#8211; Pubertas praecox<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2022-Endo-ERN-guidline-Pubertal-induction-and-transition-to-adult-sex-hormone-replacement-in-patients-with-congenital-pituitary-or-gonadal-reproductive-hormone-deficiency.pdf\">2022 &#8211; Endo-ERN guidline &#8211; Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Fausses couches \u00e0 r\u00e9p\u00e9tition<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2022-AWMF-015-050l-S2k-Diagnostik-und-Therapie-von-wiederholten-Spontanaborten.pdf\">2022 &#8211; AWMF 015-050l S2k &#8211; Diagnostik und Therapie von wiederholten Spontanaborten<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Interruption de grossesse au cours du 1er trimestre<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2023-AWMF-015-094l-S2k-Schwangerschaftsabbruch-im-ersten-Trimenon.pdf\">2023 &#8211; AWMF 015-094l S2k &#8211; Schwangerschaftsabbruch im ersten Trimenon<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Perte de grossesse au cours du 1er trimestre<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2025-AWMF-015-076l-S2k-Frueher-Schwangerschaftsverlust-im-ersten-Trimenon.pdf\">2025 &#8211; AWMF 015-076l S2k &#8211; Fr\u00fcher Schwangerschaftsverlust im ersten Trimenon<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Transidentit\u00e9<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2014-AWMF-138-001l-S3-Geschlechtsinkongruenz-Geschlechtsdysphorie-und-Trans-Gesundheit-Diagnostik-Beratung-und-Behandlung-1.pdf\">2014 &#8211; AWMF 138-001l S3 &#8211; Geschlechtsinkongruenz, Geschlechtsdysphorie und Trans-Gesundheit &#8211; Diagnostik, Beratung und Behandlung<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2016-AWMF-174-001l-S2k-Varianten-der-Geschlechtsentwicklung-1.pdf\">2016 &#8211; AWMF 174-001l S2k &#8211; Varianten der Geschlechtsentwicklung<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2025-AWMF-028-014l-S2k-Geschlechtsinkongruenz-und-Geschlechtsdysphorie-im-Kindes-und-Jugendalter-\u2013-Diagnostik-und-Behandlung.pdf\">2025 &#8211; AWMF 028-014l S2k &#8211; Geschlechtsinkongruenz und Geschlechtsdysphorie im Kindes- und Jugendalter \u2013 Diagnostik und Behandlung<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2025-AWMF-043-052l-S2k-Chirurgische-Massnahmen-bei-Geschlechtsinkongruenz.pdf\">2025 &#8211; AWMF 043-052l S2k &#8211; Chirurgische Massnahmen bei Geschlechtsinkongruenz<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Divers<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2011-AWMF-027-028l-S1-Gynaekomastie-1.pdf\">2011 &#8211; AWMF 027-028l S1 \u2013 Gyn\u00e4komastie<\/a><\/li>\n<\/ul>\n<\/details>\n<\/div>\n\n\n\n<div style=\"height:28px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-accent-3-color has-text-color has-link-color wp-elements-58be990a38ce8ca951b1071898d09924\"><strong><strong>Contraception<\/strong><\/strong><\/p>\n\n\n\n<div class=\"wp-block-group has-global-padding is-layout-constrained wp-container-core-group-is-layout-e0082cf6 wp-block-group-is-layout-constrained\">\n<details class=\"wp-block-details is-layout-flow wp-container-core-details-is-layout-8a368f38 wp-block-details-is-layout-flow\"><summary>Contraception hormonale<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2020-AWMF-015-015l-S3-Hormonelle-Empfaengnisverhuetung.pdf\">2020 &#8211; AWMF 015-015l S3 &#8211; Hormonelle Empf\u00e4ngnisverh\u00fctung<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2024-U.S.-Selected-Practice-Recommendations-for-Contraceptive-Use.pdf\">2024 &#8211; U.S. Selected Practice Recommendations for Contraceptive Use<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2024-USMEC-U.S.-Medical-Eligibility-Criteria-for-Contraceptive-Use.pdf\">2024 &#8211; USMEC &#8211; U.S. Medical Eligibility Criteria for Contraceptive Use<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2025-UKMEC-UK-Medical-Eligibility-Criteria-for-Contraceptive-Use.pdf\">2025 &#8211; UKMEC &#8211; UK Medical Eligibility Criteria for Contraceptive Use<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2025-UKMEC-UK-Medical-Eligibility-Criteria-for-Contraceptive-Use-Summary-Tables.pdf\">2025 &#8211; UKMEC &#8211; UK Medical Eligibility Criteria for Contraceptive Use &#8211; Summary Tables<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2025-UKMEC-UK-Medical-Eligibility-Criteria-for-Contraceptive-Use-Supplementary-Evidence.pdf\">2025 &#8211; UKMEC &#8211; UK Medical Eligibility Criteria for Contraceptive Use &#8211; Supplementary Evidence<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2025-UKMEC-UK-Medical-Eligibility-Criteria-for-Contraceptive-Use-Whats-New.pdf\">2025 &#8211; UKMEC &#8211; UK Medical Eligibility Criteria for Contraceptive Use &#8211; Whats New<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-container-core-details-is-layout-8a368f38 wp-block-details-is-layout-flow\"><summary>Contraception non hormonale<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2024-AWMF-015-095l-S2k-Nicht-hormonelle-Empfaengnisverhuetung.pdf\">2024 &#8211; AWMF 015-095l S2k &#8211; Nicht hormonelle Empf\u00e4ngnisverh\u00fctung<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-container-core-details-is-layout-8a368f38 wp-block-details-is-layout-flow\"><summary>Contraception d&rsquo;urgence<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2023-FSRH-Guideline-Emergency-contraception.pdf\">2023 &#8211; FSRH Guideline &#8211; Emergency contraception<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2023-Society-of-Family-Planning-Clinical-Recommendation-Emergency-contraception.pdf\">2023 &#8211; Society of Family Planning Clinical Recommendation &#8211; Emergency contraception<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-container-core-details-is-layout-8a368f38 wp-block-details-is-layout-flow\"><summary>Contraception dans des situations particuli\u00e8res<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2025-UKMEC-CoSRH-Statement-Effect-of-Hormonal-Contraception-in-Individuals-with-anxiety-and-mood-disorderes.pdf\">2025 &#8211; UKMEC &#8211; CoSRH Statement &#8211; Effect of Hormonal Contraception in Individuals with anxiety and mood disorderes<\/a><\/li>\n<\/ul>\n<\/details>\n<\/div>\n\n\n\n<div style=\"height:31px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-accent-3-color has-text-color has-link-color wp-elements-9f3b1009074ef877f1729397010a925b\"><strong><strong>M\u00e9nopause<\/strong><\/strong><\/p>\n\n\n\n<div class=\"wp-block-group has-global-padding is-content-justification-left is-layout-constrained wp-container-core-group-is-layout-0b710646 wp-block-group-is-layout-constrained\">\n<details class=\"wp-block-details alignfull is-layout-flow wp-block-details-is-layout-flow\"><summary>Insuffisance ovarienne pr\u00e9matur\u00e9e (IOP) et m\u00e9nopause pr\u00e9coce<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2021-AWMF-078-007l-S1-Molekulargenetische-Diagnostik-des-Fragilen-X-Syndroms-und-andere-FMR1-assoziierte-Syndrome.pdf\">2021 &#8211; AWMF 078-007l S1 &#8211; Molekulargenetische Diagnostik des Fragilen-X-Syndroms und andere FMR1-assoziierte Syndrome<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2024-The-ESHRE-ASRM-CREWHIRL-and-IMS-Guideline-Group-on-POI-Premature-Ovarian-Insufficiency.pdf\">2024 &#8211; The ESHRE, ASRM, CREWHIRL and IMS Guideline Group on POI &#8211; Premature Ovarian Insufficiency<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details alignfull is-layout-flow wp-block-details-is-layout-flow\"><summary>Traitement hormonal substitutif pendant la p\u00e9rim\u00e9nopause et la postm\u00e9nopause<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2021-AWMF-015-062l-S3-Diagnostik-und-Interventionen-der-Peri-Postmenopause.pdf\">2021 &#8211; AWMF 015-062l S3 &#8211; Diagnostik und Interventionen der Peri-Postmenopause<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2022-The-North-American-Menopause-Society-The-hormone-therapy-position-statement.pdf\">2022 &#8211; The North American Menopause Society &#8211; The hormone therapy position statement<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2024-IMS-White-Paper-Menopause-and-MHT-in-2024-Addressing-the-key-controversies.pdf\">2024 &#8211; IMS White Paper &#8211; Menopause and MHT in 2024 &#8211; Addressing the key controversies<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2025-Expertenbrief-Nr.-90-Aktuelle-Empfehlungen-zur-systemischen-Menopausalen-Hormontherapie.pdf\">2025 &#8211; SGGG Expertenbrief Nr. 90 &#8211; Aktuelle Empfehlungen zur systemischen Menopausalen Hormontherapie<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details alignfull is-layout-flow wp-block-details-is-layout-flow\"><summary>Traitements non hormonaux pendant la p\u00e9rim\u00e9nopause et la postm\u00e9nopause<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2021-AWMF-015-062l-S3-Diagnostik-und-Interventionen-der-Peri-Postmenopause.pdf\">2021 &#8211; AWMF 015-062l S3 &#8211; Diagnostik und Interventionen der Peri-Postmenopause<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2023-The-North-American-Society-The-nonhormone-therapy-position-statement.pdf\">2023 &#8211;&nbsp; The North American Society &#8211; The nonhormone therapy position statement<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details alignfull is-layout-flow wp-block-details-is-layout-flow\"><summary>Trouble du d\u00e9sir sexuel hypoactif<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2019-Global-Consensus-Position-Statement-on-the-Use-of-Testosterone-Therapy-for-Women.pdf\">2019 &#8211; Global Consensus Position Statement on the Use of Testosterone Therapy for Women<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2021-International-Society-for-the-Study-of-Womens-Sexual-Health-Clinical-Practice-Guideline-for-the-Use-of-Systemic-Testosterone-for-Hypoactive-Sexual-Desire-Disorder-in-Women.pdf\">2021 &#8211; International Society for the Study of Women&rsquo;s Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women<\/a><\/li>\n<\/ul>\n<\/details>\n\n\n\n<details class=\"wp-block-details alignfull is-layout-flow wp-block-details-is-layout-flow\"><summary>Divers<\/summary>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/menopause.projecttac.com\/wp-content\/uploads\/2026\/01\/2022-IMS-White-Paper-Brain-fog-in-menopause.pdf\">2022 &#8211; IMS White Paper &#8211; Brain fog in menopause<\/a><\/li>\n<\/ul>\n<\/details>\n<\/div>\n\n\n\n<div style=\"height:28px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Traiter les patientes Dans cette rubrique, la SSEGM met \u00e0 disposition des lignes directrices fond\u00e9es sur des preuves, des prises de position et des recommandations sp\u00e9cialis\u00e9es sur des th\u00e8mes centraux de l&rsquo;endocrinologie gyn\u00e9cologique, de la contraception et de la m\u00e9decine de la m\u00e9nopause. Ces contenus s&rsquo;adressent aux m\u00e9decins et visent \u00e0 favoriser des soins de [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":1200,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-364","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/menopause.projecttac.com\/fr\/wp-json\/wp\/v2\/pages\/364","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/menopause.projecttac.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/menopause.projecttac.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/menopause.projecttac.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/menopause.projecttac.com\/fr\/wp-json\/wp\/v2\/comments?post=364"}],"version-history":[{"count":41,"href":"https:\/\/menopause.projecttac.com\/fr\/wp-json\/wp\/v2\/pages\/364\/revisions"}],"predecessor-version":[{"id":1419,"href":"https:\/\/menopause.projecttac.com\/fr\/wp-json\/wp\/v2\/pages\/364\/revisions\/1419"}],"wp:attachment":[{"href":"https:\/\/menopause.projecttac.com\/fr\/wp-json\/wp\/v2\/media?parent=364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}